Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
See how your representatives voted on this bill.
DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Alignment with your views
Sign in and take the values quiz to see how this bill lines up with what you've said.
Summary
Based on the bill's title, this legislation would extend the Accelerating Access to Critical Therapies for ALS Act through fiscal year 2031. The bill amends an existing law related to expedited development and approval pathways for treatments targeting amyotrophic lateral sclerosis (ALS). Without access to the full text, the specific mechanisms and any additional provisions cannot be determined.
Values analysis
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
How your representatives voted
Sign in to see how your representatives voted on this bill.